Good to finally have news, I think the muted market response is maybe due to other investors having similar feelings to me that while good progress, the ANN doesn’t detail potential revenue from Sozo. Dunno, that’s just how I read into it at least
- Forums
- ASX - By Stock
- IPD
- Ann: US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment
IPD
impedimed limited
Add to My Watchlist
16.7%
!
0.5¢
Ann: US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment, page-3
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
